SGPGI Lucknow announces the 23rd ICMR Course on Medical Genetics & Genetic Counseling (Sept 21 – Oct 3, 2026). Read More
Chandigarh
Gujarat
Jharkhand
Rajasthan
MAMC Delhi becomes India's 8th institute to launch a DM in Medical Genetics. Offering 2 seats via NEET SS, it features advanced genomic infrastructure. Read More
Hunter syndrome, also known as Mucopolysaccharidosis type II (MPS II), is a rare genetic disorder that affects boys. Children born with this condition have a mutation in a specific gene that prevents their bodies from producing an essential enzyme called iduronate-2-sulfatase (I2S). Without this enzyme, complex molecules known as glycosaminoglycans build up inside the body’s
Experts in the field of medical genetics are preparing to gather in Bengaluru this December for the 11th Annual Conference of the Society for Indian Academy of Medical Genetics (SIAMG). Read More
Explore Apollo's Genomic Multiverse in Hyderabad on March 14, 2026. Join experts for radical debates merging genomics, ethics, and research. Read More
Beren Therapeutics P.B.C., through its subsidiary Mandos LLC, has announced that the U.S. Food and Drug Administration (FDA) has officially accepted its New Drug Application (NDA) for adrabetadex. Read More
The scientific community is preparing for the highly anticipated 5th National Symposium on Genetic Diseases (NSGDCON). Save the Date: October 24th & 25th, 2026 Read More
The Division of Genetics, Department of Pediatrics at the All India Institute of Medical Sciences (AIIMS), New Delhi, has announced the launch of a significant interventional clinical trial: ELEGANT. Read More
A new Phase 3 study, titled NAVIGATE, is currently evaluating the efficacy and safety of Nizubaglustat for patients with late-infantile and juvenile forms of Niemann-Pick Type C (NPC) and GM1/GM2 Gangliosidosis. Read More
The National Neonatology Forum (NNF) and leading clinical geneticists have debuted a monthly scientific series. The initiative aims to revolutionize NICU outcomes through expert-led sessions on genomic testing, metabolic emergencies, and dysmorphology. Read More